(Q73835683)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832102%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832102%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832102%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

E Batyreva

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832102%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

K Kaur

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832102%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

D L Sprecher

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832102%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M J Schreiber

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832102%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J W Crabb

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832102%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M S Penn

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832102%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A M DiCorletoe

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832102%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

S L Hazen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832102%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

E A Podrez

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832102%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832102%20AND%20SRC:MED&resulttype=core&format=json

Biochimica et Biophysica Acta

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832102%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

1485

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832102%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832102%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

225-235

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832102%20AND%20SRC:MED&resulttype=core&format=json

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Demential syndromes and the lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Oxidative stress: the paradox of aerobic life

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Accelerated atherosclerosis in prolonged maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Prostaglandin endoperoxides. 14. Solvent-induced fragmentation of prostaglandin endoperoxides. New aldehyde products from PGH2 and a novel intramolecular 1,2-hydride shift during endoperoxide fragmentation in aqueous solution

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Oxidation of low-density lipoproteins produces levuglandin-protein adducts

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Identification of extremely reactive gamma-ketoaldehydes (isolevuglandins) as products of the isoprostane pathway and characterization of their lysyl protein adducts

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Levuglandin E2-protein adducts in human plasma and vasculature.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Protein adducts of iso[4]levuglandin E2, a product of the isoprostane pathway, in oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Measurement of oxidation in plasma Lp(a) in CAPD patients using a novel ELISA.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Role of oxidized low density lipoprotein in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Susceptibility of low-density lipoprotein to oxidative modification

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Immunological detection of low-density lipoproteins modified by malondialdehyde in vitro or in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Distribution of immunoreactive malondialdehyde-modified low-density lipoprotein in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Prostaglandin endoperoxides 21. Covalent binding of levuglandin E2 with proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Levuglandin E2 crosslinks proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Electrophilic levuglandin E2-protein adducts bind glycine: a model for protein crosslinking

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Oxidation-specific epitopes in human coronary atherosclerosis are not limited to oxidized low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Levuglandin E2 inhibits mitosis and microtubule assembly.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Formation of DNA-protein cross-links in mammalian cells by levuglandin E2.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Macrophage recognition of LDL modified by levuglandin E2, an oxidation product of arachidonic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Brain tissue injury and blood-brain barrier opening induced by injection of LGE2 or PGE2

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

The isoprostanes. Current knowledge and directions for future research

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

Radioimmunoassay of 8-iso-prostaglandin F2alpha: an index for oxidative injury via free radical catalysed lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2800%2900038-X

7 January 2021

10.1016/S1388-1981(00)00038-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832102%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference